全文获取类型
收费全文 | 1417篇 |
免费 | 85篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 54篇 |
妇产科学 | 50篇 |
基础医学 | 151篇 |
口腔科学 | 154篇 |
临床医学 | 143篇 |
内科学 | 394篇 |
皮肤病学 | 13篇 |
神经病学 | 64篇 |
特种医学 | 31篇 |
外科学 | 218篇 |
综合类 | 5篇 |
预防医学 | 81篇 |
眼科学 | 9篇 |
药学 | 80篇 |
中国医学 | 1篇 |
肿瘤学 | 57篇 |
出版年
2023年 | 16篇 |
2022年 | 4篇 |
2021年 | 27篇 |
2020年 | 20篇 |
2019年 | 48篇 |
2018年 | 35篇 |
2017年 | 39篇 |
2016年 | 35篇 |
2015年 | 43篇 |
2014年 | 46篇 |
2013年 | 77篇 |
2012年 | 96篇 |
2011年 | 115篇 |
2010年 | 59篇 |
2009年 | 48篇 |
2008年 | 69篇 |
2007年 | 91篇 |
2006年 | 84篇 |
2005年 | 71篇 |
2004年 | 75篇 |
2003年 | 57篇 |
2002年 | 68篇 |
2001年 | 19篇 |
2000年 | 14篇 |
1999年 | 20篇 |
1998年 | 11篇 |
1997年 | 13篇 |
1996年 | 8篇 |
1995年 | 10篇 |
1994年 | 10篇 |
1993年 | 9篇 |
1992年 | 17篇 |
1991年 | 8篇 |
1990年 | 13篇 |
1989年 | 16篇 |
1988年 | 6篇 |
1987年 | 8篇 |
1986年 | 16篇 |
1985年 | 17篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1982年 | 8篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 9篇 |
1977年 | 7篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1969年 | 4篇 |
1963年 | 3篇 |
排序方式: 共有1512条查询结果,搜索用时 31 毫秒
51.
Heidi Fhær Larsen Thorbjørn Søren Rønn Jensen Lars RasmussenMark Ellebæk Niels Qvist 《Journal of pediatric surgery》2013
Background/Purpose
Surgical treatment of long-gap esophageal atresia (LGEA) is challenging. Methods which facilitate stretching of the esophageal pouches may allow primary anastomosis. Botulinum toxin type A (BTX-A) blocks acetylcholine release in neuromuscular junctions, thereby causing muscle relaxation. We hypothesized that intramural injections with BTX-A into the esophageal wall of piglets would significantly elongate the tissue upon stretch.Methods
Twenty-four piglets were randomized to receive BTX-A of placebo (saline). After one hour, the esophagus was removed en bloc and tested in a stretch-tension device.Results
The mean esophageal elongation was 84% (range 83–101) in the BTX-A-group and 65% (50–78) in the control group. The mean difference between the two groups was 18%, which was significant (p < 0.001).Conclusion
Intramural injections with botulinum toxin type A elongate the esophagus significantly. Clinically, this could be a potential method to achieve primary anastomosis in LGEA. Additional clinical studies are necessary to evaluate the method before it can be generally recommended. 相似文献52.
53.
54.
Carlsen CM Bay M Kirk V Gøtze JP Køber L Nielsen OW 《European journal of heart failure》2012,14(3):240-247
55.
Strand V Burmester GR Ogale S Devenport J John A Emery P 《Rheumatology (Oxford, England)》2012,51(10):1860-1869
Objective. To investigate the effect of tocilizumab on patient-reported outcomes (PROs) in RA patients with inadequate responses to TNF inhibitors (TNFis). Methods. In a Phase III randomized controlled trial, 489 patients received 4 or 8 mg/kg tocilizumab or placebo every 4 weeks plus MTX for 24 weeks. Mean changes from baseline over time and proportions of patients reporting improvements greater than or equal to minimum clinically important differences (MCIDs) in PROs were analyzed. Results. At week 24, 8?mg/kg resulted in significantly greater improvements vs placebo in pain, global assessment of disease activity (P?=?0.001), Health Assessment Questionnaire-Disability Index (HAQ-DI; P?0.0001), Functional Assessment of Chronic Illness Therapy-Fatigue (P?=?0.0150) and Medical Outcomes Survey Short Form 36 (SF-36 v2) Physical Component Summary (PCS; P?=?0.0003) scores, all greater than MCID; 4?mg/kg resulted in greater improvements in pain (P?=?0.0100), HAQ-DI (P?=?0.0030) and SF-36 PCS (P?=?0.0020) scores. Tocilizumab-associated improvements were evident as early as week 2. At week 24, more tocilizumab-treated than control patients reported improvements greater than or equal to MCID in SF-36 domain scores and related PROs (50.9-84.9% vs 35.0-51.7%) and achieved ACR50 responses and/or Disease Activity Score 28 (DAS28) remission with PRO improvements greater than or equal to MCID (36.2-51.2% vs 10-20.7% and 10.7-37.5% vs 0.0-3.4%, respectively). Conclusion. Tocilizumab treatment in patients with inadequate responses to TNFis resulted in rapid and sustained improvements in multiple PROs that were statistically significant and clinically meaningful, consistent with previous efficacy reports. Trial Registration. ClinicalTrials.gov, http://clinicaltrials.gov/, NCT00106522. 相似文献
56.
TB Wyller LO Watne A Torbergsen K Engedal F Frihagen V Juliebø I Saltvedt E Skovlund J Ræder S Conroy 《BMC geriatrics》2012,12(1):36
ABSTRACT: BACKGROUND: Hip fracture mainly affect older people. It is associated with high morbidity and mortality, and in particular a high frequency of delirium. Incident delirium following hip fracture is associated with an increased risk of dementia in the following months, but it is still not firmly established whether this is an association or a causal relationship. Orthogeriatric units vary with respect to content and timing of the intervention. One main effect of orthogeriatric care may be the prevention of delirium, especially if preoperative and postoperative care are provided. Thus, the aim of Oslo Orthogeriatric Trial, is to assess whether combined preoperative and postoperative orthogeriatric care can reduce the incidence of delirium and improve cognition following hip fracture. Methods/design: Inclusion and randomisation will take place in the Emergency Department, as soon as possible after admission. All patients with proximal femur fractures are eligible, irrespective of age, pre-fracture function and accommodation, except if the fracture is caused by a high energy trauma or the patient is terminally ill. The intervention is pre-and post-operative orthogeriatric care delivered on a dedicated acute geriatric ward. The primary outcome measure is a composite endpoint combining the Clinical Dementia Rating Scale (CDR) and the 10 word memory task at four months after surgery. Secondary outcomes comprise incident delirium, length of stay, cognition, mobility, place of residence, activities of daily living and mortality, measured at 4 and 12 months after surgery. We have included 332 patients in the period 17th September 2009 to 5th January 2012. DISCUSSION: Our choice of outcome measures and our emphasis of orthogeriatric care in the preoperative as well as the postoperative phase will enable us to provide new knowledge on the impact of orthogeriatric care on cognition. Trials registration: ClinicalTrials.gov NCT01009268. 相似文献
57.
Kamper-Jørgensen Z Andersen AB Kok-Jensen A Bygbjerg IC Thomsen VO Lillebaek T 《Tuberculosis (Edinburgh, Scotland)》2012,92(3):226-231
Molecular genotyping studies often focus on clustered tuberculosis and recent transmission. Less attention has been paid to non-clustered tuberculosis. However, non-clustered cases also contribute significantly to the tuberculosis burden, especially in low-incidence countries. The objective of this study is to characterize non-clustered tuberculosis cases in Denmark and point out potential implications for tuberculosis control. The study is based on nationwide IS6110-RFLP genotyping of tuberculosis cases from 1992 through 2004, corresponding to 98% of culture verified cases. Of 3988 cases, 45% were non-clustered. Both Danes and immigrants had a peak incidence of non-clustered tuberculosis at older ages, 80-89 years (4.3 cases/10(5) population/year) and 60-69 years (28.8 cases/10(5) population/year), respectively. In addition, immigrants had a peak at 20-29 years (43.2?cases/10(5) inhabitants/year). In Danes, the incidence of non-clustered tuberculosis decreased during the study period and was predominantly found in elderly persons, presumably reactivating infection acquired during 1910-40, when tuberculosis incidence was high. In immigrants, the incidence was high at all ages, presumably reflecting reactivation of imported infections. In the future, the number of non-clustered tuberculosis cases will decrease, as older Danes die, and as time since primary infection increases for immigrants residing in Denmark. TB control should include focus on non-clustered cases. 相似文献
58.
BackgroundA better understanding of the environmental factors leading to inflammatory bowel disease should help to prevent occurrence of the disease and its relapses.AimTo review current knowledge on dietary risk factors for inflammatory bowel disease.MethodsThe PubMed, Medline and Cochrane Library were searched for studies on diet and risk of inflammatory bowel disease.ResultsEstablished non-diet risk factors include family predisposition, smoking, appendectomy, and antibiotics. Retrospective case–control studies are encumbered with methodological problems. Prospective studies on European cohorts, mainly including middle-aged adults, suggest that a diet high in protein from meat and fish is associated with a higher risk of inflammatory bowel disease. Intake of the n-6 polyunsaturated fatty acid linoleic acid may confer risk of ulcerative colitis, whereas n-3 polyunsaturated fatty acids may be protective. No effect was found of intake of dietary fibres, sugar, macronutrients, total energy, vitamin C, D, E, Carotene, or Retinol (vitamin A) on risk of ulcerative colitis. No prospective data was found on risk related to intake of fruits, vegetables or food microparticles (titanium dioxide and aluminium silicate).ConclusionsA diet high in protein, particular animal protein, may be associated with increased risk of inflammatory bowel disease and relapses. N-6 polyunsaturated fatty acids may predispose to ulcerative colitis whilst n-3 polyunsaturated fatty acid may protect. These results should be confirmed in other countries and in younger subjects before dietary counselling is recommended in high risk subjects. 相似文献
59.
60.
S. Bülow H. Højen S. Buntzen K. L. Larsen L. Preisler N. Qvist 《Colorectal disease》2013,15(4):436-441
Aim The aim of the study was to evaluate intra‐operative difficulties, complications and long‐term bowel function in polyposis patients undergoing conversion of an ileorectal anastomosis to an ileoanal pouch, compared with patients with a primary ileoanal pouch operation. Method A national register‐based retrospective study was performed with clinical follow‐up and a questionnaire on long‐term bowel function. Results There were 84 patients in the study: 59 (70%) had a primary pouch operation and in 25 (30%) a secondary pouch procedure was attempted. This was abandoned, in one case, leaving 24 patients who had a successful secondary restorative proctocolectomy. The median (range) follow‐up was 123 (0–359) months. There were no intra‐operative difficulties in the 59 primary operations, but intra‐operative difficulties were reported in nine of 25 secondary operations (P < 0.001). Complications within 1 month of surgery occurred in six of 59 primary operations and in none of 24 secondary operations (P < 0.001); and late surgical complications occurred in eight of 55 primary operations and in eight of 24 secondary operations (P = 0.13). The only difference in bowel function was a lower frequency of nocturnal defaecation after secondary pouch formation (P = 0.02). Conclusion Reoperation with proctectomy after a previous ileorectal anastomosis and conversion to restorative proctocolectomy is feasible in polyposis patients, with morbidity and functional results similar to those seen after a primary pouch operation. 相似文献